Từ điển y khoa

Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5693603-(4-chlorophenyl)adamantane-1-carboxylic acid 3,4-dihydroxybenzylamideMeSH

  inhibits both sphingosine kinases 1 and 2; structure in first source

• C5881403-(4-ethylphenylmethyl)-1-(glucopyranosyl)indoleMeSH

  inhibits renal sodium-dependent glucose cotransporter 2; structure in first source

• C5711053-(4-fluoro-2-methoxy-benzyl)-7-hydroxy-8,9-dihydro-3H,7H-pyrrolo(2,3-c)(1,7)naphthyridin-6-oneMeSH

  structure in first source

• C5724113-(4-fluorobenzoyloxy)tropaneMeSH

  a local anesthetic; structure in first source

• C5753393-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-indoleMeSH

  a PET radiotracer; structure in first source

• C5686203-(4-fluorophenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno(1,2-c)pyrazole-2-carbothioamideMeSH

  has antineoplastic activity; structure in first source

• C5833773-(4-fluorophenyl)-N-(4-bromophenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno(1,2-c)pyrazole-2-carboxamideMeSH

  structure in first source

• C5617543-(4-hydroxyphenyl)-4-(2-morpholinoethoxy)furan-2(5H)-oneMeSH

  structure in first source

• C5730243-(4-hydroxyphenyl)-4-(4-thiomethoxyphenyl)-1H-pyrrole-2,5-dioneMeSH

  structure in first source

• C5693223-(4-methoxy-3-methyl-2-oxo-2H-pyran-6-yl)butylpyroglutamateMeSH

  from the endophytic fungus of Cephalotaxus hainanensis; structure in first source

• C5747123-(4-methoxybenzoyl)-1-pentylindoleMeSH

  structure in first source

• C5851633-(4-methoxyphenyl)-3-(trifluoromethyl)-3H-diazirineMeSH

  structure in first source

• C5697983-(4-pyridyl)-1H-indoleMeSH

  structure in first source

• C5723263-(4-pyridylmethyl)-2',3'-di-O-oleyl-5'-O-(benzyloxy)hexaethylene glycol-acetyl-uridineMeSH

  structure in first source

• C5723253-(4-pyridylmethyl)-3'-O-oleyl-5'-O-(benzyloxy)hexaethylene glycol-acetyl-thymidineMeSH

  structure in first source

• C5723243-(4-pyridylmethyl)-3'-O-oleyl-5'-O-(monomethoxy)triethylene glycol-acetyl-thymidineMeSH

  structure in first source

• C5833743-(4H-1,2,4-triazol-3-ylthio)-N-phenylpropanamideMeSH

  structure in first source

• C5784923-(5-((7aR)-6-(5-fluoropyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1H-pyrrolo(3,4-d)pyrimidin-7a-yl)thiophen-3-yl)benzonitrileMeSH

  structure in first source

• C5610583-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridineMeSH

  a partial PPARgamma agonist and antagonist of angiotensin II type 1 receptor; structure in first source

• C5622443-(5-(4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl)-2-trifluoromethylphenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dioneMeSH

  structure in first source

• C5689123-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acidMeSH

  an antiarthritic agent that inhibits c-Fos/activator protein-1; structure in first source

• C5709453-(5-carboxypentanoyl)-1-(3-(4-octylphenoxy)-2-oxopropyl)indole-5-carboxylic acidMeSH

  for therapy of inflammatory skin disorders; structure in first source

• C5784843-(5-chloro-2-furoyl)-3,7-diazabicyclo(3.3.0)octaneMeSH

  a nicotinic acetylcholine receptor agonist; structure in first source

• C5829113-(5-chlorofuran-2-yl)-4-phenyl-5-(trifluoromethyl)isoxazoleMeSH

  a COX-1 inhibitor; structure in first source

• C5698613-(5-cyano-4-(4-methyl-2-(methylamino)thiazol-5-yl)pyrimidin-2-ylamino)benzenesulfonamideMeSH

  CDK9 inhibitor; structure in first source

• C5834503-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-(2-(3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino)-ethyl)-propionamideMeSH

  structure in first source

• C5732863-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-oneMeSH

  antineoplastic agent that induces methuosis; structure in first source

• C5795583-(5-tert-butylisoxazol-3-yl)-2-((3-chlorophenyl)hydrazono)-3-oxopropionitrileMeSH

  an EPAC protein antagonist; structure in first source

• C5882653-(6-(2-methoxyethyl)pyridin-3-yl)-2-methyl-8-morpholin-4-ylimidazo(1,2-a)pyrazineMeSH

  inhibits phosphodiesterase 10A; structure in first source

• C5826603-(6-(4-oxo-4H-1,3-benzothiazin-2-yl)pyridin-2-yl)propanoic acidMeSH

  structure in first source

• C5844103-(6-amino-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenolMeSH

  inhibits ALK2 protein; structure in first source

• C5788003-(7-((4'-chlorobiphenyl-4-yl)methoxy)-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanoic AcidMeSH

  structure in first source

• C5787983-(7-(biphenyl-4-ylmethoxy)-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanoic AcidMeSH

  structure in first source

• C5622423-(7-trifluoromethyl-5-(2-trifluoromethylphenyl)-1H-benzimidazol-2-yl)-1-oxa-2-azaspiro(4.5)dec-2-eneMeSH

  a TRPM8 channel antagonist; structure in first source

• C5852683-(8-(2-(cyclohexylmethyl(2,3-dihydroxypropionyl)amino)ethyl)-8-azabicyclo(3.2.1)oct-3-yl)benzamideMeSH
• C5840533-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dioneMeSH

  structure in first source

• C5839493-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaboroleMeSH

  structure in first source

• C5790383-(aminomethyl)benzo(c)(1,2)oxaborol-1(3H)-olMeSH

  structure in first source

• C5875683-(anthracen-10-yl)-5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazoleMeSH

  structure in first source

• C5870003-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridineMeSH

  desensitizes alpha4beta2 nicotinic receptors; structure in first source

• C5761363-(b-D-2-ribofuranosyl)-6-methylpyrrolo(2,3-d)pyrimidin-2(3H)-oneMeSH

  pyrrolocytosine; structure in first source

• C5733203-(benzo(d)-1,3-dioxol-5-yl)-4-phenylfuran-2,5-dioneMeSH

  has anti-inflammatory activity; structure in first source

• C5863783-(but-3-enyl)oxyquinoloneMeSH

  structure in first source

• C5877303-(butylamino)-4-((3-(dimethylamino)propyl)(methyl)amino)cyclobut-3-en-1,2-dioneMeSH

  an anti-Chagasic agent; structure in first source

• C5683663-(cyclopropylamino)-5-(3-(trifluoromethyl)phenylamino)pyrimido(4,5-c)quinoline-8-carboxylic acidMeSH

  structure in first source

• C5616253-(didodecyl(2-hydroxyethyl)ammonio)propane-1-sulfonateMeSH

  a zwitterionic sultaine surfactant; structure in first source

• C5610503-(diethylamino)-N-(4,9-dioxo-4,9-dihydronaphtho(2,3-b)thiophen-3-yl)propanamideMeSH

  has antineoplastic activity; structure in first source

• C5696893-(dimethylamino-ethylamino)-8-oxo-8H-acenaphthol(1,2-b)pyrrole-9-carboxylic acidMeSH

  structure in first source

• C5796283-(fur-2-yl)-10-(2-phenylethyl)-(1,2,4)triazino(4,3-a)benzimidazol-4(10H)-oneMeSH

  structure in first source

• C5723513-(guanin-9-yl)pyrrolidin-N-ylcarbonylphosphonic acidMeSH

  structure in first source